2.066USD+1.30%Mkt Cap: 23.92M USDP/E: 206.65Last update: 2026-06-01
TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States and internationally. Its products portfolio includes IMVEXXY for the treatment of moderate-to-severe dyspareunia, a symptom of vulvar…
Industry Peers
Drug Manufacturers - Specialty & Generic150.78BSEKP/E 166.4
58.93BTRY—
56.89BEURP/E 22.4
32.78BPLNP/E 21.4
23.20BUSDP/E 20.2
18.39BUSD—
16.21BUSDP/E 24.8
13.00BTRY—
Indicators:|
Key Statistics
Company
Market Cap23.92M USD
Enterprise Value21.06M USD
Revenue (TTM)3.35M USD
Gross Profit3.35M USD
Net Income (TTM)-569.00K USD
Revenue/Share0.2900 USD
Last Price2.066 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees1
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)206.65
P/E (Forward)6.11
PEG—
EV/EBITDA-14.97
EV/Revenue6.28
P/S7.39
P/B0.92
EPS (TTM)0.01
EPS (Forward)0.35
52W Range
0.980055% of range2.950
52W High2.950 USD
52W Low0.9800 USD
Profitability
Gross Margin100.00%
Oper. Margin-28.45%
EBITDA Margin-41.96%
Profit Margin-18.83%
ROE-2.12%
ROA-1.51%
Growth
Revenue Growth84.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF2.45M USD
CapEx (TTM)—
FCF Margin39.64%
FCF Yield5.56%
Net Debt-3.60M USD
Net Debt/EBITDA2.56
Balance Sheet
Debt/Equity0.23
Current Ratio3.11
Quick Ratio2.37
Book Value/Sh2.322 USD
Cash/Share0.7270 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:50
Split DateMay 9, 2022
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.11.57M
Float9.49M
Insiders7.45%
Institutions33.97%
Short Interest
Short Ratio2.4d
Short % Float0.63%
Short % Out.0.46%
Shares Short53.08K
Short (prev mo.)52.19K
Technical
SMA 502.092 (-1.2%)
SMA 2001.760 (+17.4%)
Beta—
S&P 52W Chg27.70%
Avg Vol (30d)18.82K
Avg Vol (10d)15.22K
Technical Indicators
RSI (14)46.3
MACD-0.0001
MACD Signal-0.0099
MACD Hist.+0.0099
BB Upper2.147 USD
BB Middle2.042 USD
BB Lower1.936 USD
BB Width10.31%
ATR (14)0.1064 USD
Vol Ratio (20d)0.73x